◆ 会议时间：2025年3月10-12日
◆ 会议地点：英国 哈罗盖特

◆ 会议简介：

2025年英国内分泌学会年会(SFE BES 2025)将于2025年3月10-12日在英国哈罗盖特举行。SfE BES是内分泌学会(SfN)的年度会议，是英国最大的内分泌会议，预计有超过1000名专业人士代表参会。为期三天的课程方案将最好的基础科学、转化研究、临床调查和临床实践结合在了一起。SfE BES将吸引世界级的国际演讲嘉宾，包括全体讲座，以及协会的奖章演讲、座谈会、临床管理研讨会、会见专家会议、护士会议和临床辩论等形式。会议包括口头交流和海报展示，并提供各种奖项和奖品。SfE BES年会包括一个大型展览和社交活动，来自全球的内分泌专家将一起交流知识，分享经验并加强合作，是与新老同事宣联系，掌握最新的科学和临床实践的平台。英国内分泌学会（SfE）成立于1946年，是一个的非营利性会员组织，是全球内分泌学领域的领导者，SfE致力于通过推进临床内分泌教育研究和科学来改善公众健康。未经许可禁止复制摘录转载本站任何内容-国际医学会议网（lingyuint.com）

SfE BES 2025 - Annual conference of the Society for Endocrinology (SfE)

Dates: 10-12 March, 2025
Location: Harrogate, UK

Sponsor: Society for Endocrinology (SfE)

SfE BES is the annual conference of the Society for Endocrinology, bringing together the best of basic science, translational research, clinical investigation and clinical practice over a three day programme.

摘要征文投稿：

Abstract Deadline: Monday 28 October 2024 (11:59pm GMT)
Late Breaking Deadline: Monday 16 December 2024 (11:59pm GMT)

点此提交摘要>>>Submit Abstract>>>

Submitting your abstract

Sharing your work at SfE BES 2025 is a fantastic opportunity to get useful feedback and ideas to progress your work, as well as boosting your presentation and networking skills.

The Society for Endocrinology hopes to attract a wide range of endocrine related research to its conference to be shared and viewed by members of the field. Below you will find information about submitting your abstract, what will happen if you are successful and the abstract category list for SfE BES 2025:

• Abstracts should be no longer than 300 words (including numbers, symbols and tables) and you must select one category from the below list. The use of figures or photographs are not permitted.
• Abstracts are accepted on the understanding that the work has not been published or presented elsewhere, excluding associated Society for Endocrinology events.

Please note: you will be required to register to the submission system and then verify your email address before being able to submit your abstract.

Abstract category list for SfE BES 2025:

• Adrenal & Cardiovascular
• Bone & Calcium
• Endocrine Cancer & Late Effects
• Metabolism, Obesity & Diabetes
• Neuroendocrinology & Pituitary
• Nursing Practice
• Reproductive Endocrinology
• Thyroid
• Innovation in teaching and assessment

Successful abstracts

• Accepted abstracts are presented at the conference either as a poster or as an oral presentation. They will also be published online in Endocrine Abstracts – a fully open access and citable record of the abstracts presented at the conference. View the abstracts from SfE BES 2023. 
  
  
• Any author failing to present an accepted abstract at this conference will automatically be excluded from submitting any future abstracts
• The Programme Committee reserves the right of the final decision regarding acceptance of abstracts and the form of presentation
• Abstracts are marked blind (anonymously). Please note that the reviewing panel for abstracts submitted to the nursing category predominantly includes nurses
  

Case reports 

Please note: case reports will only be accepted if they illustrate something significantly new or especially unusual in the clinical case load of the submitting endocrine unit.

Conditions of acceptance

Notification of acceptance or rejection of abstracts/cases will be sent to authors in November 2024 before the Early-bird registration deadline.

Detailed instructions concerning oral presentations and poster sessions will be emailed to qualifying authors with notification of acceptance.

Please note, abstracts that are accepted as poster presentation will need to be displayed on A0 portrait poster boards.

Prizes and awards

Early career presenting authors of accepted abstracts may be considered for a range of prizes and awards, which are presented during the conference and recognised at the SfEBES 2025 awards ceremony.

注册费：

To benefit from the Society for Endocrinology Early-Bird Registration member rate, please ensure you complete your membership application by Friday, 6 December (11:59pm GMT).

◆ 参会对象：医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。